119 related articles for article (PubMed ID: 10882184)
1. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
Oguogho A; Ferlitsch A; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
[TBL] [Abstract][Full Text] [Related]
3. Isoprostanes in atherosclerosis.
Oguogho A; Sinzinger H
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):673-82. PubMed ID: 11192940
[TBL] [Abstract][Full Text] [Related]
4. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of LDL-apheresis on cholesterol oxidation products and antioxidants in plasma and lipoproteins of patients with familial hypercholesterolemia.
Linseisen J; Wilhelm M; Hoffmann J; Hailer S; Keller C; Wolfram G
Eur J Med Res; 1999 Oct; 4(10):433-41. PubMed ID: 10527957
[TBL] [Abstract][Full Text] [Related]
6. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M
Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia.
Oguogho A; Mehrabi M; Sinzinger H
Wien Klin Wochenschr; 1999 Feb; 111(3):113-8. PubMed ID: 10093893
[TBL] [Abstract][Full Text] [Related]
9. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
10. Regular ingestion of opuntia robusta lowers oxidation injury.
Budinsky A; Wolfram R; Oguogho A; Efthimiou Y; Stamatopoulos Y; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):45-50. PubMed ID: 11487308
[TBL] [Abstract][Full Text] [Related]
11. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
Sachais BS; Katz J; Ross J; Rader DJ
J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
[TBL] [Abstract][Full Text] [Related]
13. [LDL-apheresis: current status].
Stefanutti C; Vivenzio A; Lucani G; Di Giacomo S
Clin Ter; 2001; 152(1):65-9. PubMed ID: 11382172
[TBL] [Abstract][Full Text] [Related]
14. [Single passive smoking exposure induces no measurable oxidation of low density lipoproteins].
Oguogho A; Kritz H; Sinzinger H
Wien Klin Wochenschr; 1996; 108(18):589-92. PubMed ID: 9012143
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
Opole IO; Belmont JM; Kumar A; Moriarty PM
Am J Cardiol; 2007 Nov; 100(9):1416-8. PubMed ID: 17950800
[TBL] [Abstract][Full Text] [Related]
16. Facilitated nitration and oxidation of LDL in cigarette smokers.
Yamaguchi Y; Haginaka J; Morimoto S; Fujioka Y; Kunitomo M
Eur J Clin Invest; 2005 Mar; 35(3):186-93. PubMed ID: 15733073
[TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial.
Tasaki H; Yamashita K; Saito Y; Bujo H; Daida H; Mabuchi H; Tominaga Y; Matsuzaki M; Fukunari K; Nakazawa R; Tsuji M; Kawade Y; Yamamoto S; Ueda Y; Takayama K
Ther Apher Dial; 2006 Feb; 10(1):32-41. PubMed ID: 16556134
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
Mabuchi H; Higashikata T; Kawashiri MA
Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
[TBL] [Abstract][Full Text] [Related]
19. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
